150 related articles for article (PubMed ID: 32443297)
1. Screening and identification of key biomarkers for retinoblastoma: Evidence from bioinformatics analysis.
Huang J; Zhang L; Li Z; Lu X
Medicine (Baltimore); 2020 May; 99(20):e19952. PubMed ID: 32443297
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of key biomarkers for retinoblastoma.
Zhao XM; Li YB; Sun P; Pu YD; Shan MJ; Zhang YM
J Int Med Res; 2021 Jun; 49(6):3000605211022210. PubMed ID: 34187205
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma gene expression profiling based on bioinformatics analysis.
Mao J; Lu M; Lu S; Xing Y; Xu X; Chen Y; Xu H; Zuo W; Zhou J; Du W
BMC Med Genomics; 2023 May; 16(1):101. PubMed ID: 37179305
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination-Related miRNA-mRNA Interaction Is a Potential Mechanism in the Progression of Retinoblastoma.
Chen X; Chen S; Jiang Z; Gong Q; Tang D; Luo Q; Liu X; He S; He A; Wu Y; Qiu J; Li Y; Wang X; Yu K; Zhuang J
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):3. PubMed ID: 34347012
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
8. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma.
Shi K; Zhu X; Wu J; Chen Y; Zhang J; Sun X
Bioengineered; 2021 Dec; 12(1):5950-5970. PubMed ID: 34482803
[TBL] [Abstract][Full Text] [Related]
11. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
12. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
Lv J; Li L
Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
[TBL] [Abstract][Full Text] [Related]
13. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma.
Wang Z; Chen N; Liu C; Cao G; Ji Y; Yang W; Jiang Q
Biochem Biophys Res Commun; 2022 Jul; 614():138-144. PubMed ID: 35594577
[TBL] [Abstract][Full Text] [Related]
14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
15. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
17. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
18. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing that Cell Cycle Deregulation Is a Key Process in Retinoblastoma Tumorigenesis.
Nie C; Ma H; Gao Y; Li J; Tang Z; Chen Y; Lu R
Ophthalmologica; 2021; 244(1):51-59. PubMed ID: 32146475
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract][Full Text] [Related]
20. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
